Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers

Tue, 14 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CARLSBAD, Calif., May 13, 2013 /PRNewswire/ --

Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine

Wed, 08 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa today announced that it has been granted United States patent (No. No 8,417,661) titled Method for Quantifying Amplitude of a Response of a Biological Network. This...

BioElectronics Corporation New Patent Published

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

FREDERICK, Md., May 7, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics...

MagForce Nanotechnologies Receives Further Patent Related to NanoTherm®Therapy

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERLIN--(Marketwired - May 07, 2013) - MagForce AG / MagForce AG Receives Further PatentRelated to NanoTherm® Therapy.

Processed and transmitted by Thomson Reuters...

GE Global Research Researcher Receives 200th U.S. Patent

Mon, 06 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NISKAYUNA, N.Y.--(BUSINESS WIRE)--GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE) is honored to announce that Dr. E. Trifon Laskaris, Chief Engineer and pioneer in imaging...

LamdaGen Corporation Issued United States Patent for Diagnostics on Plasmonic-Based Nanosensors

Wed, 24 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif., April 24, 2013 /PRNewswire/ -- LamdaGen Corporation, a nano-technology platform company that provides...

BIOLASE Technology, Inc. Awarded New Patent for Non-Contact Handpiece for Tissue Cutting

Tue, 16 Apr 2013 12:00:00 AM GMT

IRVINE, CA--(Marketwired - April 16, 2013) - BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that the U.S. Patent and Trademark Office has issued BIOLASE a new patent for its non-contact handpiece for cutting both hard and soft tissue with its...

Antares Pharma, Inc. Announces the Issuance of a New Patent on VIBEX™ Device Platform

Tue, 16 Apr 2013 12:00:00 AM GMT

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the issuance of U.S. Patent number 8,419,686 which relates to the device-injection site contacting interface. The interface design is applicable to the entire Antares VIBEX injector device platform. Paul K. Wotton, Ph.D., President and Chief Executive Officer, stated, This is another example of the importance of our...

DiaGenic ASA Patent Allowed in Canada

Thu, 11 Apr 2013 12:00:00 AM GMT

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) has received notice of allowance for its Canadian family 2 patent application. The allowed claims cover the use of a set of gene sequences in blood essential for the diagnosis of, among other diseases, Alzheimers disease and stages thereof. The patent when granted will be valid until 2023.

Avita Medical Release: Granted Japanese Patent Expands Commercial Rights for ReCell® Spray-On Skin® Technology in Asia

Wed, 10 Apr 2013 12:00:00 AM GMT

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - April 10, 2013) -

Highlighted Links

Avita Medical website

Japanese Patent Covers Technology Embodied...

True Diagnostics, Inc. Receives Notice of Patent Allowance Covering Its Quantitative Testing Device and Method

Wed, 10 Apr 2013 12:00:00 AM GMT

SAN DIEGO, CA--(Marketwired - April 10, 2013) - True Diagnostics, Inc.™ (www.TrueDiagnostics.com), a company dedicated to the discovery and development of innovative diagnostic solutions, announced today it has received Notice of Allowance from...

LamdaGen Corporation Announces Japan Patent Issuance for Enzymatic Diagnostic Assays on Plasmonic Nano-Sensors

Thu, 04 Apr 2013 12:00:00 AM GMT

MENLO PARK, Calif., April 4, 2013 /PRNewswire/ -- LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the Japanese Patent Office issuance of patent number 5203390, "Enzymatic Assays for LSPR", which enables...

T2 Biosystems Announces Issuance of Patent Covering T2Candida® Assay

Wed, 03 Apr 2013 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued a patent, number US8,409,807 (the 807 patent), covering T2Candida, the Companys flagship diagnostic test. T2Candida identifies sepsis-causing Candida species directly from whole blood at ~1CFU/mL sensitivity...

Kalila Medical Announces Issuance of Key Patent For truVector™ Technology for Steerable Introducer Sheaths

Tue, 02 Apr 2013 12:00:00 AM GMT

CAMPBELL, Calif., April 2, 2013 /PRNewswire/ -- Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced the issuance of U.S. Patent No. 8,323,241 by the US Patent and Trademark Office (USPTO), titled "Steerable Medical...

AxioMed Spine Corporation Receives Pivotal Total Disc Design Patent

Tue, 02 Apr 2013 12:00:00 AM GMT
GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed Spine Corporation (www.axiomed.com) announces the Notice of Allowance of a key US patent which describes a device for replacing a damaged spinal disc. The key feature of the allowed patent is the trapezoidal shape which is asserted to be a closer approximation of the spinal disc anatomy. The initial application of this invention is the introduction...

Rheonix, Inc. Expands Intellectual Property Portfolio With U.S. Patent for a Fully Automated Molecular Platform

Tue, 02 Apr 2013 12:00:00 AM GMT
ITHACA, N.Y. Rheonix Inc., the developer of automated molecular diagnostic testing platforms, has been issued a patent protecting self-contained instruments for purifying, amplifying, and analyzing one or more target nucleic acid sequences necessary for performing a molecular test. The claims of the patent protect Rheonixs EncompassMDx instrument. The instrument performs a wide range of molecular...

Hansen Medical Announces the Filing of 30 New U.S. Patent Applications Related to Flexible Medical Robotics

Mon, 01 Apr 2013 12:00:00 AM GMT

MOUNTAIN VIEW, CA--(Marketwire - April 01, 2013) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it has recently filed 30 new patent applications with the U.S. Patent and Trademark Office relating to flexible medical robotics, based on research and development...

BioElectronics Corporation Obtains Additional US Patent for Its Unique Pain Devices

Mon, 01 Apr 2013 12:00:00 AM GMT

FREDERICK, Md., April 1, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics, announced today that the Company has received notice from the United States Patent and Trademark Office that patent number 8,412,328 is being issued.
This new US patent, our...

Vycor Medical Inc. Issued Hong Kong Patent for Its VBAS Minimally Invasive Brain Access System

Mon, 25 Mar 2013 12:00:00 AM GMT

BOCA RATON, FL--(Marketwire - March 25, 2013) - Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced it has been issued patent number 10106385.8 for its ViewSite͐...

FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT Imaging

Fri, 22 Mar 2013 12:00:00 AM GMT

MONTCLAIR, NJ--(Marketwire - March 22, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced...

Nanomix, Inc. Awarded Patent for Carbon Nanotube Sensor Technology

Tue, 19 Mar 2013 12:00:00 AM GMT

EMERYVILLE, Calif., March 18, 2013 /PRNewswire/ -- Nanomix Inc., (Nanomix), a leading nanotechnology company focused on development of next generation point of care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, announced today that the United States Patent...

Hatch Medical Announces Issuance of Two Patents for Percutaneous Spinal Stabilization System

Tue, 19 Mar 2013 12:00:00 AM GMT
ATLANTA--(BUSINESS WIRE)--Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C. today announced the issuance of US Patent No. 8,357,197 and US Patent No. 8,357,198 related to their percutaneous spinal stabilization system. Hatch Medical previously entered into a joint venture with physician inventor J. Kevin McGraw, M.D. to develop and market the microinvasive spinal stabilization...

DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases

Mon, 18 Mar 2013 12:00:00 AM GMT

GAITHERSBURG, Md., March 18, 2013 /PRNewswire/ -- DioGenix, Inc. announced today that the United States Patent and Trademark Office has issued a patent that broadly protects DioGenix' proprietary next-generation sequencing assay, MSPrecise, that has shown in recent clinical studies to accurately...

Puritan Medical Products Company, LLC Awarded U.S. Patent for PurFlock® Ultra Flocked Swab Collection Device

Tue, 12 Mar 2013 12:00:00 AM GMT
GUILFORD, Maine--(BUSINESS WIRE)--Puritan Medical Products, North Americas largest manufacturer of single-use medical products, announced today that it has received a new United States patent for its high-performance PurFlock Ultra swab, marking the second collection device patent the company has been awarded for flocked swabs since December. This second collection device patent for our PurFlock...

Ivera Medical Corporation Asserts New Patent Against Excelsior Medical Corporation SwabCap

Fri, 01 Mar 2013 12:00:00 AM GMT

SAN DIEGO, CA--(Marketwire - February 28, 2013) - Ivera Medical Corporation, headquartered in San Diego, CA, filed suit today against Excelsior Medical Corporation of Neptune, NJ, for patent infringement by Excelsior's SwabCap® product. The suit was filed in the U.S. District Court for the Southern District of California in San Diego, CA.
Ivera manufactures, markets...

Amedica Corporation Expands Patent Portfolio With Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain

Thu, 28 Feb 2013 12:00:00 AM GMT

SALT LAKE CITY, Feb. 28, 2013 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, announced today that the company received a new patent for an artificial spinal disc implant based on its proprietary Silicon Nitride...

mPhase Technologies, Inc. New Patent Application Would Protect the Delivery of Preset Topical Dosages

Thu, 28 Feb 2013 12:00:00 AM GMT

LITTLE FALLS, NJ--(Marketwire - February 27, 2013) - mPhase Technologies, Inc. (OTCBB: XDSL) announced today that on the heels of filing a US letter patent application for automatic dispensing of preset dosages for a drug delivery system that the Nanodermatology Society declared 2013 the year of Topical Delivery...

T2 Biosystems Announces Patent Covering In Vivo Application of Direct Detection Technology

Thu, 28 Feb 2013 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent 8,368,402 (the 402 patent), NMR systems for in vivo detection of analytes. This patent covers the use of the Companys T2MR technology in an implantable device for the in vivo monitoring of a target...

BioElectronics Corporation Announces Publication of Patent Application

Tue, 26 Feb 2013 12:00:00 AM GMT

FREDERICK, Md., Feb. 26, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices, announced today that the World Intellectual Property Organization has published the International Patent Application for RF Induced Thermal...

MPEG LA's Librassay® Removes Patent Barriers to Diagnostics for Personalized Medicine

Fri, 22 Feb 2013 12:00:00 AM GMT
(DENVER, CO, US 27 September 2012) MPEG LA announced today that Librassay, a landmark collaboration with the National Institutes of Health (NIH) and other leading healthcare innovators (listed below), is now providing one-stop worldwide access to diagnostic discoveries for personalized medicine.
Uncertainties surrounding access to patented technologies have imperiled healthcare...

Direct Flow Medical, Inc. Awarded Two New Patents for Proprietary Design of Its Transcatheter Aortic Valve System

Thu, 21 Feb 2013 12:00:00 AM GMT
SANTA ROSA, Calif., Feb 21, 2013 (BUSINESS WIRE) -- Direct Flow Medical(R), Inc., a transcatheter heart valve innovator focused on improving patient outcomes, today announced it has been awarded U.S. Patent No. 8,377,118 by the U.S. Patent and Trademark Office (USPTO) and Japanese Patent No. 5,119,148 by the Japan Patent Office. The company's proprietary technology encompasses a distinctive transcatheter...

Rosetta Genomics Ltd. Receives Two Key U.S. Patent Allowances

Thu, 14 Feb 2013 12:00:00 AM GMT

PHILADELPHIA and REHOVOT, Israel, Feb. 14, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that the Company has received two notices of allowance from the U.S. Patent and Trademark...

TissueGen, Inc. and Biomedical Structures LLC Announce Availability of Breakthrough Drug Delivery Platform for Implantable Devices

Wed, 13 Feb 2013 12:00:00 AM GMT

DALLAS, TX and WARWICK, RI--(Marketwire - February 12, 2013) -
Highlighted Links

TissueGen Homepage

OrbusNeich Announces Favorable Ruling From the European Patent Office

Tue, 12 Feb 2013 12:00:00 AM GMT

FORT LAUDERDALE, Fla., Feb. 12, 2013 /PRNewswire/ -- OrbusNeich Medical, Inc. ("OrbusNeich") announced that it received a favorable ruling from the European Patent Office ("EPO") yesterday in connection with its European Patent EP1 341 482. The '482 patent covers certain novel stents with helical structures. ...

mPhase Technologies, Inc. Files U.S. Letter Patent Application for Drug Delivery System

Tue, 12 Feb 2013 12:00:00 AM GMT

LITTLE FALLS, NJ--(Marketwire - February 12, 2013) - mPhase Technologies, Inc. (OTCBB: XDSL) said today that it has filed a United States Letter Patent application for a novel drug delivery system based on its Smart Surface technology.
The drug delivery patent is based on mPhase's Smart Surface technology...

MiMedx is Issued Four Additional U.S. Patents for Placental Tissue Grafts

Mon, 11 Feb 2013 12:00:00 AM GMT

KENNESAW, Ga., Feb. 11, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four new issued patents related to tissue...

Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria

Thu, 07 Feb 2013 12:00:00 AM GMT

WAYNE, Pa., Feb. 7, 2013 /PRNewswire/ -- Molecular Detection Inc. (MDI), which develops and markets Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced major patent advances in the US and Europe. A second core US patent has issued covering...

BIOLASE Technology, Inc. Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma

Thu, 07 Feb 2013 12:00:00 AM GMT

IRVINE, CA--(Marketwire - February 07, 2013) -
Highlighted Links

www.biolase.com
BIOLASE, Inc. (NASDAQ: BIOL), the world...

Andrew Technologies, Inc. Obtains Patent for Visceral Lipectomy Application From USPTO

Wed, 06 Feb 2013 12:00:00 AM GMT

IRVINE, Calif., Feb. 6, 2013 /PRNewswire/ -- Andrew Technologies, LLC was issued a patent by the US Patent and Trademark Office (USPTO) that provides exclusivity for their Tissue Liquefaction Technology to be used for the removal of visceral fat; the dangerous and metabolically active fat that is attached to...

The Better Way Back®, a NuVasive, Inc. Patient Education Program, Reaches 1,000 Patient Ambassadors

Tue, 05 Feb 2013 12:00:00 AM GMT

SAN DIEGO, CA--(Marketwire - February 05, 2013) - NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is pleased to announce that The Better Way Back®, a NuVasive supported patient education program...

Commitment to Research Earns Carestream Health, Inc. 43 U.S. Patents in 2012

Thu, 31 Jan 2013 12:00:00 AM GMT
ROCHESTER, N.Y.--(BUSINESS WIRE)--Carestream was awarded 43 patents from the U.S. Patent and Trademark Office in 2012 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, capping another strong year for technology development across its businesses.

mPhase Technologies, Inc. Issued Patent No. 8,372,531 for Reserve Battery System

Wed, 30 Jan 2013 12:00:00 AM GMT

mPower Jump, 'Wherever You Go You're in Charge' <...

Colibri Heart Valve, LLC Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System

Tue, 29 Jan 2013 12:00:00 AM GMT
BROOMFIELD, CO, Jan. 29, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. More particularly, today the U.S. Patent & Trademark Office granted Colibri U.S. Patent No. 8,361,144 entitled, "Percutaneously Deliverable Heart Valve Device And Methods Associated Therewith." The patent is directed...

T2 Biosystems Announces Issuance of Patents Covering Components of the T2Dx Direct Detection Device

Tue, 29 Jan 2013 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two design patents covering components of the T2Dx direct detection device. These patents, USD673,293 and USD674,112, describe cartridge designs for the Companys T2Candida assay, which is run on the T2Dx platform...

mPhase Technologies, Inc. Receives Notice of Allowance for Key Smart Surface Patent

Thu, 24 Jan 2013 12:00:00 AM GMT

LITTLE FALLS, NJ--(Marketwire - January 24, 2013) - mPhase Technologies, Inc. (OTCBB: XDSL) reported today that it has received a Notice of Allowance from the U.S. Patent & Trademark Office (USPTO) of a Key Smart Surface Patent.
The invention is a key patent for mPhase Technologies in its continuing...

Nevro Corp Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment

Thu, 24 Jan 2013 12:00:00 AM GMT
MENLO PARK, Calif.--(BUSINESS WIRE)--Nevro Corp., a medical device company focused on improving the lives of patients suffering from debilitating chronic pain, announced today the issuance of four additional key patents related to the companys Senza system and HF10 SCS therapy.

BioElectronics Corporation Announces South Korean Patent Allowance for its Innovative OTC Pain Relief Medical Devices

Tue, 22 Jan 2013 12:00:00 AM GMT

FREDERICK, Md., Jan. 22, 2013 /PRNewswire/ -- BioElectronics Corporation (OTCPK: BIEL), maker of consumer medical electronics, announced today that the Company has received patent allowance from the South Korean Intellectual Property office.
While pulsed shortwave therapy is an established medical therapy...

Catheter Connections Announces Issuance of a Sixth Patent Covering its IV Disinfection Technology

Fri, 18 Jan 2013 12:00:00 AM GMT
SALT LAKE CITY--(BUSINESS WIRE)--Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,343,112. This is the sixth patent issued to the Company in a portfolio that broadly covers its DualCap technology for disinfecting IV connectors - technology which helps protect hospital...

Aggredyne Increases IP Portfolio to Four Patents

Tue, 15 Jan 2013 12:00:00 AM GMT
HOUSTON--(BUSINESS WIRE)--Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function, has added a fourth patent to its intellectual property portfolio. The new patent, "Systems for Measuring Properties of a Physiologic Fluid Suspension," provides the foundation to expand the AggreGuideTM platform to other coagulation tests, including heparin...

Hygieia Receives Notice of Allowance for Key Patent Covering Diabetes Insulin Guidance System (DIGS™)

Mon, 14 Jan 2013 12:00:00 AM GMT

ANN ARBOR, Mich., Jan. 14, 2013 /PRNewswire/ -- Hygieia, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims broadly covering the company's Diabetes Insulin Guidance System (DIGS) technology. The patent application entitled "System for Optimizing a Patient's Insulin...

Nocimed Announces Recent Patent Issuances in United States & Australia

Wed, 09 Jan 2013 12:00:00 AM GMT
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Nocimed, LLC is pleased to announce that U.S. patent number 8,344,728 for Systems and Methods Using Nuclear Magnetic Resonance (NMR) Spectroscopy to Evaluate Pain and Degenerative Properties of Tissue was issued by the United States Patent and Trademark Office (USPTO) on January 1, 2013. Another patent in a related family to this issued U.S. patent was also...

mPhase Technologies, Inc. Issued Patent No. 8,344,543

Wed, 02 Jan 2013 12:00:00 AM GMT

'Wherever You Go You're in Charge'
LITTLE FALLS...

Bio-AMD Patent Application for Immunoassay Result Reading Apparatus

Fri, 28 Dec 2012 12:00:00 AM GMT

LONDON, Dec. 28, 2012 /PRNewswire/ -- Bio-AMD, Inc. is pleased to announce that Bio AMD Limited, our majority owned medical devices subsidiary ("Bio-AMD", "We" or the "Company") (OTCBB: BIAD.OB), (OTCQB: BIAD) has submitted a UK Intellectual Property Office patent application for an Immunoassay Result Reading...

Oculus Innovative Sciences, Inc. Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn® Technology

Thu, 27 Dec 2012 12:00:00 AM GMT
PETALUMA, Calif., Dec. 27, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) a healthcare company that designs, produces and markets innovative, safe and effective anti-infective products and medical devices while also developing multiple drug candidates, today announced the issuance of new U.S. patent for the use of Microcyn Technology in the treatment of skin ulcers. In this...

T2 Biosystems Announces Issuance of Patent for Direct Detection Diagnostic Device and Methods

Tue, 18 Dec 2012 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent number 8,334,693 (the 693 patent), NMR device for detection of analytes. The 693 patent covers the T2MR platform, which is used in T2 Bios T2Dx device for direct detection of analytes, including T...

Sequenom Inc. Provides Update on Status of Patent for Methods of Detecting Fetal Aneuploidy

Mon, 17 Dec 2012 12:00:00 AM GMT

SAN DIEGO, Dec. 14, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the U.S. Patent and Trademark Office has withdrawn the issuance of U.S. Patent No. 8,340,916. Sequenom has been informed by the Patent and Trademark...

Tangent Medical Technologies, Inc. Announces Issuance of U.S. Patent

Wed, 12 Dec 2012 12:00:00 AM GMT

ANN ARBOR, MI--(Marketwire - December 12, 2012) - Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products, today announced the issuance of US Patent #8,323,249 for technology included in the NovaCath™ Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design...

Sequenom Inc. Announces Issuance of Patent for Methods of Detecting Fetal Aneuploidy

Fri, 07 Dec 2012 12:00:00 AM GMT

SAN DIEGO, Dec. 6, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the U.S. Patent and Trademark Office will issue U.S. Patent No. 8,340,916 on December 25, 2012 with claims to...

Vystar Corporation Receives New U.S. Patent

Thu, 06 Dec 2012 12:00:00 AM GMT

ATLANTA, Dec. 6, 2012 /PRNewswire/ -- Vystar Corporation (OTCBB: VYST) ("Vystar" or the "Company"), the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural raw material that contains significantly reduced levels of non-rubber particles and proteins found in natural rubber...

MiMedx Issued First U.S. Patent for Placental Tissue Grafts

Thu, 06 Dec 2012 12:00:00 AM GMT

KENNESAW, Ga., Dec. 6, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of the Company's first issued patent related...

Illumina, Inc. Patent Claim May be Reconsidered

Mon, 26 Nov 2012 12:00:00 AM GMT
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NAS: ILMN) announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California granted Illumina's request to file a motion seeking reconsideration of the Court's October 16, 2012 ruling invalidating certain claims of U.S. Patent No. 6,306,597, which is being asserted by Illumina against Complete Genomics...

International Drug & Explosives Detection Company IDenta Corporation Receives Patent for New Sniffer

Tue, 20 Nov 2012 12:00:00 AM GMT

JERUSALEM, Nov. 20, 2012 /PRNewswire/ -- IDenta Corp. (OTC Pink: IDTA) CEO Yaacov Shoham today announced the following updates regarding the new IDenta Sniffer.
1. We have received the provisional patent for it. It is EFS ID 13788673
2. WE HAVE FINISHED THE PROTOTYPE...

Quantum Materials Corporation, Inc. Release: Revolutionary Tetrapod Quantum Dot Synthesis US Patent Granted

Tue, 20 Nov 2012 12:00:00 AM GMT

CARSON CITY, Nev., Nov. 20, 2012 /PRNewswire/ -- Quantum Materials Corporation, Inc. (OTCQB: QTMM) proudly announces the USPTO patent grant of a fundamental disruptive technology for synthesis of Group II-VI inorganic tetrapod quantum dots

Sanovas, Inc. Receives Patent Allowance for Nested Balloon Catheter for Localized Drug Delivery

Mon, 19 Nov 2012 12:00:00 AM GMT

SAUSALITO, Calif., Nov. 19, 2012 /PRNewswire/ -- Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United...

The Thermometer Meets the Smart Phone: Technology that Help Moms and Saves Lives

Fri, 16 Nov 2012 12:00:00 AM GMT
Body temperature.

Its an essential element to being a good mom and a good doctor. Its a gauge of the human bodys well being and plays a valuable role in the management of many diseases, not the least of which is infection. Every intern, parent and caregiver knows that feeling when your patient spikes a temperature. Sometimes, its a human touch and yet other times its the...

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

Wed, 14 Nov 2012 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two patents adding depth and breadth to the Companys intellectual property portfolio. These patents cover both the device and methods related to the Companys flagship T2Candida assay and the detection of additional...

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

Wed, 14 Nov 2012 12:00:00 AM GMT
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two patents adding depth and breadth to the Companys intellectual property portfolio. These patents cover both the device and methods related to the Companys flagship T2Candida assay and the detection of additional...

Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood

Tue, 06 Nov 2012 12:00:00 AM GMT

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice...

Micell Technologies Announces Issuance of Core Technology Patent

Tue, 06 Nov 2012 12:00:00 AM GMT

DURHAM, N.C., Nov. 6, 2012 /PRNewswire/ -- Micell Technologies, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a patent covering the company's surface and polymer modification technology. This intellectual property protection is related to Micell's investigational MiStent...

SpinalCyte, LLC Receives U.S. Patent for Spinal Disc Regeneration

Mon, 05 Nov 2012 12:00:00 AM GMT
HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the U.S. Patent Office issued Patent # 8,298,560 Methods and Compositions For Repair Of Cartilage Using An In Vivo Bioreactor to regrow the spinal disc. The allowed claims include the use of human dermal fibroblasts from the...

Ariste Medical Receives Issued U.S. Patent and Raises Seed Capital

Tue, 30 Oct 2012 12:00:00 AM GMT
MEMPHIS, Tenn.--(BUSINESS WIRE)--Ariste Medical, Inc., announced today that a key patent has been issued by the United States Patent and Trademark Office (USPTO). The U.S. patent (#8,236,338) covers a formulation capable of coating polytetrafluoroethylene (PTFE) and expanded PTFE, more commonly known as Teflon and Gore-Tex, respectively. The novel coating is capable of incorporating multiple pharmaceutical...

Aethlon Medical Announces Issuance of Cancer Therapy Patent

Thu, 25 Oct 2012 12:00:00 AM GMT

SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that U.S. Patent number 8,288,172 was issued to the Company by the...

BioSpace.com News

IMRIS Announces US Patent for Microsurgical Robot Concept

Senior Scientific Announces Issuance of U.S. Patent for the Detection, Measurement and Imaging of Cancer Cells Using Nanoparticles

Soligenix Announces Issuance of US Patent for Its ThermoVax™ Technology

KFx Medical Corporation Announces Allowance From United States Patent Office of Two Additional Orthopedic Surgical Patents

Catheter Connections Announces Patent Notices of Allowance and Confirms Rejection of Ivera Medical Corporation's Patent Claims in Reexamination

Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific Corporation

DebMed Announces US Patent

BIOLASE Technology, Inc. Awarded Two New Patents

Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers

Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine

BioElectronics Corporation New Patent Published

MagForce Nanotechnologies Receives Further Patent Related to NanoTherm®Therapy

GE Global Research Researcher Receives 200th U.S. Patent

LamdaGen Corporation Issued United States Patent for Diagnostics on Plasmonic-Based Nanosensors

BIOLASE Technology, Inc. Awarded New Patent for Non-Contact Handpiece for Tissue Cutting

Antares Pharma, Inc. Announces the Issuance of a New Patent on VIBEX™ Device Platform

DiaGenic ASA Patent Allowed in Canada

Avita Medical Release: Granted Japanese Patent Expands Commercial Rights for ReCell® Spray-On Skin® Technology in Asia

True Diagnostics, Inc. Receives Notice of Patent Allowance Covering Its Quantitative Testing Device and Method

LamdaGen Corporation Announces Japan Patent Issuance for Enzymatic Diagnostic Assays on Plasmonic Nano-Sensors

T2 Biosystems Announces Issuance of Patent Covering T2Candida® Assay

Kalila Medical Announces Issuance of Key Patent For truVector™ Technology for Steerable Introducer Sheaths

AxioMed Spine Corporation Receives Pivotal Total Disc Design Patent

Rheonix, Inc. Expands Intellectual Property Portfolio With U.S. Patent for a Fully Automated Molecular Platform

Hansen Medical Announces the Filing of 30 New U.S. Patent Applications Related to Flexible Medical Robotics

BioElectronics Corporation Obtains Additional US Patent for Its Unique Pain Devices

Vycor Medical Inc. Issued Hong Kong Patent for Its VBAS Minimally Invasive Brain Access System

FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT Imaging

Nanomix, Inc. Awarded Patent for Carbon Nanotube Sensor Technology

Hatch Medical Announces Issuance of Two Patents for Percutaneous Spinal Stabilization System

DioGenix Issued Seminal Patent for Diagnosing Early-stage Neurological Diseases

Puritan Medical Products Company, LLC Awarded U.S. Patent for PurFlock® Ultra Flocked Swab Collection Device

Ivera Medical Corporation Asserts New Patent Against Excelsior Medical Corporation SwabCap

Amedica Corporation Expands Patent Portfolio With Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain

mPhase Technologies, Inc. New Patent Application Would Protect the Delivery of Preset Topical Dosages

T2 Biosystems Announces Patent Covering In Vivo Application of Direct Detection Technology

BioElectronics Corporation Announces Publication of Patent Application

MPEG LA's Librassay® Removes Patent Barriers to Diagnostics for Personalized Medicine

Direct Flow Medical, Inc. Awarded Two New Patents for Proprietary Design of Its Transcatheter Aortic Valve System

Rosetta Genomics Ltd. Receives Two Key U.S. Patent Allowances

TissueGen, Inc. and Biomedical Structures LLC Announce Availability of Breakthrough Drug Delivery Platform for Implantable Devices

OrbusNeich Announces Favorable Ruling From the European Patent Office

mPhase Technologies, Inc. Files U.S. Letter Patent Application for Drug Delivery System

MiMedx is Issued Four Additional U.S. Patents for Placental Tissue Grafts

Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria

BIOLASE Technology, Inc. Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma

Andrew Technologies, Inc. Obtains Patent for Visceral Lipectomy Application From USPTO

The Better Way Back®, a NuVasive, Inc. Patient Education Program, Reaches 1,000 Patient Ambassadors

Commitment to Research Earns Carestream Health, Inc. 43 U.S. Patents in 2012

mPhase Technologies, Inc. Issued Patent No. 8,372,531 for Reserve Battery System

Colibri Heart Valve, LLC Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System

T2 Biosystems Announces Issuance of Patents Covering Components of the T2Dx Direct Detection Device

mPhase Technologies, Inc. Receives Notice of Allowance for Key Smart Surface Patent

Nevro Corp Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment

BioElectronics Corporation Announces South Korean Patent Allowance for its Innovative OTC Pain Relief Medical Devices

Catheter Connections Announces Issuance of a Sixth Patent Covering its IV Disinfection Technology

Aggredyne Increases IP Portfolio to Four Patents

Hygieia Receives Notice of Allowance for Key Patent Covering Diabetes Insulin Guidance System (DIGS™)

Nocimed Announces Recent Patent Issuances in United States & Australia

mPhase Technologies, Inc. Issued Patent No. 8,344,543

Bio-AMD Patent Application for Immunoassay Result Reading Apparatus

Oculus Innovative Sciences, Inc. Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Treatment of Skin Ulcers With Microcyn® Technology

T2 Biosystems Announces Issuance of Patent for Direct Detection Diagnostic Device and Methods

Sequenom Inc. Provides Update on Status of Patent for Methods of Detecting Fetal Aneuploidy

Tangent Medical Technologies, Inc. Announces Issuance of U.S. Patent

Sequenom Inc. Announces Issuance of Patent for Methods of Detecting Fetal Aneuploidy

Vystar Corporation Receives New U.S. Patent

MiMedx Issued First U.S. Patent for Placental Tissue Grafts

Illumina, Inc. Patent Claim May be Reconsidered

International Drug & Explosives Detection Company IDenta Corporation Receives Patent for New Sniffer

Quantum Materials Corporation, Inc. Release: Revolutionary Tetrapod Quantum Dot Synthesis US Patent Granted

Sanovas, Inc. Receives Patent Allowance for Nested Balloon Catheter for Localized Drug Delivery

The Thermometer Meets the Smart Phone: Technology that Help Moms and Saves Lives

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

T2 Biosystems Announces Issuance of Patents Covering T2MR Direct Detection Technology

Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood

Micell Technologies Announces Issuance of Core Technology Patent

SpinalCyte, LLC Receives U.S. Patent for Spinal Disc Regeneration

Ariste Medical Receives Issued U.S. Patent and Raises Seed Capital